Alexandra Balcom, MBA, CPA, is the Chief Financial Officer at Nuvalent Inc Class A, a biopharmaceutical company focused on developing precision oncology therapies. With an impressive background in finance and accounting, Balcom brings a wealth of experience to her role. She holds a Master of Business Administration degree and is a Certified Public Accountant, demonstrating her strong foundation in financial management and strategic planning. Prior to joining Nuvalent, Balcom held various senior financial positions at several well-known companies in the biotechnology and pharmaceutical industries. Her expertise in financial strategy, budgeting, and risk management has been instrumental in driving growth and ensuring the financial health of the organizations she has served. Balcom's ability to navigate complex financial landscapes and her keen understanding of the unique challenges faced by companies in the life sciences sector have made her an invaluable asset to Nuvalent. As the Chief Financial Officer at Nuvalent, Balcom plays a crucial role in shaping the company's financial strategy and overseeing its financial operations. She works closely with the executive team to develop and implement financial plans that support Nuvalent's mission of bringing innovative cancer treatments to patients. Balcom's leadership and financial acumen have been key factors in Nuvalent's success, helping the company to secure funding, manage resources effectively, and position itself for long-term growth in the competitive biopharmaceutical market.